SCHEMBL18653153

SCHEMBL18653153

C/C=N\c1cc(C)c(F)cc1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15488761 0.74 CYP3A4 (0.48) —
SCHEMBL799411 0.74 MAPT (0.44) —
SCHEMBL14360194 0.73 LMNA (0.39) —
SCHEMBL24455167 0.72 GRIA1 (0.38) —
SCHEMBL261036 0.72 ACHE (0.42) —
SCHEMBL24455159 0.71 CYP1A2 (0.30) —
SCHEMBL24455106 0.71 ALDH1A1 (0.41) —
SCHEMBL22791405 0.70 SIGMAR1 (0.32) —
SCHEMBL24455123 0.68 SMN1; SMN2 (0.35) —
SCHEMBL20808852 0.68 CYP3A4 (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2678334-B1 ANTI-VIRAL COMPOUNDS ABBVIE BAHAMAS LTD (BS) 2017-03-22 — — EP disclosed
Send feedback